Dr. Jonathan S. Dosik, MD

Dr. Dosik practices at Quest Diagnostics Incorporated in Clifton, New Jersey.

Dr. Dosik's NPI, 1396704755, was assigned on March 22, 2006. Dr. Dosik graduated from New York University School of Medicine in 1996. Dr. Dosik holds New Jersey license MA70663.

Dr. Dosik's primary practice is Quest Diagnostics Incorporated, at 881 Allwood Rd, Clifton, NJ 07012 in Passaic County. The practice phone is (862) 349-2010.

Dr. Dosik's primary practice is Quest Diagnostics Incorporated in Clifton, New Jersey. The medical group on file is Dermatology Associates of Glen Rock. Dmand AI also links Dr. Dosik to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dosik practices. Vendor and product names are available with a free account.

Dermatology is Dr. Dosik's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Dosik is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Dosik's licenses on file in 2 states: New Jersey and New York.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, hives, itchy rashes and psoriasis among the conditions Dr. Dosik treats.

CMS data shows 4,576 Medicare services from Dr. Dosik across 16 procedure codes in 2024, for 1,109 Medicare patients. Medicare paid $267,042 for them. Every service was in an office.

CMS counts 1,109 Medicare patients who saw Dr. Dosik in 2024. The largest group is 75 to 84, with 460 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dosik's median patient age at 68, with 42% women.

In 2024, Dr. Dosik wrote 1,140 Medicare Part D claims for 490 patients. 92% of them were for generic drugs. CMS names the drug for 974 of them, across 21 drugs with 11 or more claims each, at $169,026 in total drug cost. In 2023, CMS named 948 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Dosik for performance year 2024, reported as part of a group. CMS counts 966 procedures of skin biopsy by Dr. Dosik, more than 99% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Dosik, published from 2016 to 2022. 2016 was the busiest year, with 2. The most frequent topics are Gels, Skin and Adapalene. Dr. Dosik has published most often in Cutis. Dr. Dosik's most frequent co-author is David M. Nanus, MD.

Dmand AI links Dr. Dosik to 8 clinical trials, 3 of them phase 1 studies. Conditions studied include Keratosis, Actinic, Keratosis and Alopecia. Open Payments lists research payments to Dr. Dosik that name 2 trials.

CMS Open Payments shows 59 general payments to Dr. Dosik from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Janssen Pharmaceuticals, Inc paid the most, $629. It also lists 57 research payments totaling $353,111 from 2016 to 2019, naming 2 clinical trials.

Dmand AI lists 1 award for Dr. Dosik.

Dr. Dosik graduated from New York University School of Medicine in 1996. Dr. Dosik is a member of AAD.

Dr. Dosik is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.